DE3681578D1 - Verfahren zur herstellung eines makromolekularen, mit einer biologisch aktiven substanz beladenen traegers, der so erhaltene gegenstand und seine verwendung. - Google Patents

Verfahren zur herstellung eines makromolekularen, mit einer biologisch aktiven substanz beladenen traegers, der so erhaltene gegenstand und seine verwendung.

Info

Publication number
DE3681578D1
DE3681578D1 DE8686903706T DE3681578T DE3681578D1 DE 3681578 D1 DE3681578 D1 DE 3681578D1 DE 8686903706 T DE8686903706 T DE 8686903706T DE 3681578 T DE3681578 T DE 3681578T DE 3681578 D1 DE3681578 D1 DE 3681578D1
Authority
DE
Germany
Prior art keywords
ldl
active substance
biologically active
pct
lyophilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686903706T
Other languages
English (en)
Inventor
Michele Masquelier
Curt Peterson
Mikael Ros
Mats Rudling
Sigurd Vitols
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncholab AB
Original Assignee
Oncholab AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncholab AB filed Critical Oncholab AB
Application granted granted Critical
Publication of DE3681578D1 publication Critical patent/DE3681578D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE8686903706T 1985-06-17 1986-06-17 Verfahren zur herstellung eines makromolekularen, mit einer biologisch aktiven substanz beladenen traegers, der so erhaltene gegenstand und seine verwendung. Expired - Fee Related DE3681578D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8502998A SE456136B (sv) 1985-06-17 1985-06-17 Forfarande for framstellning av en med ett lipofilt biologiskt aktivt emne bemengd berare pa basis av rekonstituerat ldl (lagdensitetslipoprotein)
PCT/SE1986/000291 WO1986007540A1 (en) 1985-06-17 1986-06-17 Method for the preparation of a macromolecular carrier loaded with a biologically active substance, product thus obtained and use thereof

Publications (1)

Publication Number Publication Date
DE3681578D1 true DE3681578D1 (de) 1991-10-24

Family

ID=20360603

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686903706T Expired - Fee Related DE3681578D1 (de) 1985-06-17 1986-06-17 Verfahren zur herstellung eines makromolekularen, mit einer biologisch aktiven substanz beladenen traegers, der so erhaltene gegenstand und seine verwendung.

Country Status (11)

Country Link
US (1) US4868158A (de)
EP (1) EP0229100B1 (de)
JP (1) JPS62502549A (de)
AT (1) ATE67412T1 (de)
AU (1) AU583402B2 (de)
DE (1) DE3681578D1 (de)
DK (1) DK168785B1 (de)
FI (1) FI86802C (de)
NO (1) NO169048C (de)
SE (1) SE456136B (de)
WO (1) WO1986007540A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2609399A1 (fr) * 1987-01-13 1988-07-15 Ire Celltarg Sa Procede d'incorporation d'un ou plusieurs principes actifs lipophiles dans des lipoproteines, lipoproteines obtenues et composition pharmaceutique les contenant
FR2664500B1 (fr) * 1990-07-13 1994-10-28 Lille Ii Universite Droit Sant Procede de preparation d'une lipoproteine modifiee par incorporation d'une substance active lipophile, lipoproteine modifiee ainsi obtenue et composition pharmaceutique ou cosmetique la contenant.
AU665599B2 (en) * 1991-11-08 1996-01-11 Hemosol Inc. Hemoglobins as drug delivery agents
CA2117749A1 (en) * 1992-04-08 1993-10-28 Paavo Kai Johannes Kinnunen Composition for therapeutic or diagnostic use, process for its preparation and its use
AU690592B2 (en) * 1993-11-08 1998-04-30 Peptide Delivery Systems Pty Ltd Labelled diagnostic compositions and methods of their use
EP0728019A4 (de) * 1993-11-08 1999-07-07 Peptide Delivery Systems Pty L Maskierte diagnostikpräparate und verfahren für ihre verwendung
US5652339A (en) * 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins
JP2001503735A (ja) * 1996-07-03 2001-03-21 ユニバーシティ オブ ピッツバーグ 親水性活性試薬のためのエマルジョン処方物
AUPP032097A0 (en) * 1997-11-11 1997-12-04 Peptide Delivery Systems Pty Ltd Improved labelled diagnostic compositions and methods of their use
US6514523B1 (en) 2000-02-14 2003-02-04 Ottawa Heart Institute Research Corporation Carrier particles for drug delivery and process for preparation
US20090110739A1 (en) * 2007-05-15 2009-04-30 University Of North Texas Health Science Center At Forth Worth Targeted cancer chemotherapy using synthetic nanoparticles
US8734853B2 (en) 2008-11-17 2014-05-27 University Of North Texas Health Science Center At Fort Worth HDL particles for delivery of nucleic acids
US9763892B2 (en) 2015-06-01 2017-09-19 Autotelic Llc Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods
AU2021252164A1 (en) 2020-04-09 2022-12-15 Finncure Oy Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ180199A (en) * 1976-03-04 1978-11-13 New Zealand Dev Finance Method of testing for the presence of elevated plasma liprotein concentration
US4186192A (en) * 1978-12-18 1980-01-29 Cutter Laboratories, Inc. Stabilized immune serum globulin
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4356117A (en) * 1980-10-23 1982-10-26 U.S. Govt., Dept. Of Health & Human Services Chemical modifications of proteins which induce new receptor specificities and therefore elicit new effects in cells
JPS5967228A (ja) * 1982-10-07 1984-04-16 Green Cross Corp:The 寒冷不溶性グロブリンの凍結乾燥方法
US4478829A (en) * 1983-04-28 1984-10-23 Armour Pharmaceutical Company Pharmaceutical preparation containing purified fibronectin
NZ208241A (en) * 1984-05-22 1987-09-30 John Stephen Ayers Purification of blood plasma or serum: selective removal of (very) low density lipoproteins (ldl and vldl)
EP0238645A1 (de) * 1985-10-03 1987-09-30 Biotechnology Research Partners, Ltd. Neue arzneimittel verabreichende systeme auf der basis von lipoproteinen

Also Published As

Publication number Publication date
NO169048C (no) 1992-05-06
NO870545D0 (no) 1987-02-11
SE8502998D0 (sv) 1985-06-17
FI870644A (fi) 1987-02-16
FI86802C (fi) 1992-10-26
AU5996886A (en) 1987-01-13
EP0229100B1 (de) 1991-09-18
US4868158A (en) 1989-09-19
ATE67412T1 (de) 1991-10-15
EP0229100A1 (de) 1987-07-22
DK77787D0 (da) 1987-02-16
WO1986007540A1 (en) 1986-12-31
DK168785B1 (da) 1994-06-13
FI86802B (fi) 1992-07-15
FI870644A0 (fi) 1987-02-16
NO870545L (no) 1987-02-11
JPH0586935B2 (de) 1993-12-14
DK77787A (da) 1987-02-16
AU583402B2 (en) 1989-04-27
JPS62502549A (ja) 1987-10-01
SE8502998L (sv) 1986-12-18
SE456136B (sv) 1988-09-12
NO169048B (no) 1992-01-27

Similar Documents

Publication Publication Date Title
DE3681578D1 (de) Verfahren zur herstellung eines makromolekularen, mit einer biologisch aktiven substanz beladenen traegers, der so erhaltene gegenstand und seine verwendung.
Singh et al. Regulation of gonadal steroidogenesis in Fundulus heteroclitus by recombinant salmon growth hormone and purified salmon prolactin
Heller‐Steinberg Ground substance, bone salts, and cellular activity in bone formation and destruction
Sharp Aseptic autolysis in rabbit and bovine muscle during storage at 37
CHAKRAVARTY et al. Mechanism of tho Release by Componnd 48/80 of Histamine and of a Lipid‐Soluble Smooth Muscle Stimulating Principle (“SRS”)
DK0495187T3 (da) Protein-nanomatricer og fremstillingsmetode.
Fell The role of organ cultures in the study of vitamins and hormones
Haller et al. Alcoholic rhabdomyolysis: an experimental model in the rat
KR900007432A (ko) 물함유 유기용매에 의하여 얻은 추출물을 함유하는 조성물 및 그 제조방법
Van Noorden et al. Cytochemical and immunofluorescence investigations on polypeptide hormone localization in the pancreas and gut of the larval lamprey
FI912687A0 (fi) Araban fraon vilken foergreningar avlaegsnats och dess anvaendning som fettersaettare.
Arffmann Heated fats and allied compounds as carcinogens: a critical review of experimental results
Seneca et al. The in vitro production of cortisone by mammalian cells
ZA884513B (en) Drug emulsion
CASLEY‐SMITH Some observations on the electron microscopy of lipids
Thompson Inability of Sheep to Develop Antihormone to the Gonadotropic Hormone from Sheep-Pituitary Glands.
Fingerman et al. The role of cations in the actions of the hormones controlling the red chromatophores of the prawn, Palaemonetes vulgaris
Jensen Eptatretin: a potent cardioactive agent from the branchial heart of the Pacific hagfish, Eptatretus stoutii
Vandenberg et al. Adenyl cyclase in the haemocytes of the American cockroach
KR890701596A (ko) 알카로이드 추출
WENDEL et al. A cytochemical approach to the lipid composition of mitochondrial matrix granules in brown adipose tissue and liver
Sørensen et al. On mitochondrial inclusions in granulosa lutein cells of pregnant cows
King et al. Vitamin D from sterols of mummified Egyptian brain
Ryder Jr et al. Serum calcium and hepatic Kupffer cell phagocytosis
Bicknell et al. Mechanism of action of somatostatin: growth-hormone release [45Ca] calcium ion efflux and cyclic nucleotide metabolism of bovine anterior-pituitary slices in the presence of prostaglandin E2 and 1-methyl-3-isobutylxanthine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee